文献速递慢性肾脏病肾血管病与高血压

代谢紊乱相关肾病的风险分层

Risk stratification of metabolic disorder-associated kidney disease.
PubMed 文献 · Kidney Int · 2025-03-27

本文综述代谢紊乱相关肾病的风险分层。过去20年代谢紊乱疾病负担增加49.4%,代谢紊乱是CKD和CVD的风险因素,近期提出CKM综合征概念。综述总结传统代谢风险因素、CKM健康概念、CKD进展和CVD风险评估方法及现有工具缺口。

要点

  • 代谢紊乱疾病负担20年增49.4%,是CKD和CVD明确风险因素
  • CKM综合征强调代谢风险因素、CKD与CVD病理生理相互关联
  • 一般临床可联合CKM分期、CKD-PC方程和PREVENT方程评估风险

核心结论

  • 代谢紊乱相关肾病患者可联合CKM staging model、CKD Prognosis Consortium方程和PREVENT方程评估CKM健康及相关风险。
  • 需要更高效的风险预测工具,可能整合多模态数据,以更准确早期识别高风险个体并实现更好个性化管理。

研究设计与样本

  • 综述,总结代谢紊乱相关肾病的传统代谢风险因素、CKM健康概念、CKD进展和CVD风险评估方法及现有工具缺口。

主要发现

  • 过去20年代谢紊乱导致的疾病负担增加49.4%。
  • 代谢紊乱是CKD和CVD的既定风险因素。
  • 代谢紊乱相关肾病的两个主要不良结局是心血管疾病和肾衰竭,中心血管疾病更重要。

关键数值与推荐

  • 一般临床环境中,代谢紊乱相关肾病患者的CKM健康及相关风险可通过联合CKM staging model、CKD Prognosis Consortium的CKD进展方程和PREVENT方程评估。

临床怎么用

  • 在一般临床环境中,可联合CKM staging model、CKD Prognosis Consortium方程和PREVENT方程对代谢紊乱相关肾病患者进行风险分层。

局限性

  • 当前风险分层工具存在关键缺口,需要更高效且可能整合多模态数据的预测工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

During the last 20 years, the disease burden attributable to metabolic disorders increased by 49.4%. Metabolic disorders are established risk factors for both chronic kidney disease (CKD) and cardiovascular disease (CVD). A concept of cardiovascular-kidney-metabolic (CKM) syndrome has recently been proposed to underscore the pathophysiological interrelatedness of the metabolic risk factors, CKD, and CVD. Two major adverse outcomes of the metabolic disorder-associated kidney disease are cardiovascular disease and, to a less extent, kidney failure. This review aims to briefly summarize the traditional metabolic risk factors for kidney disease; to introduce the concept of CKM health; to present the methods for risk assessment for CKD progression and CVD, with focus on validated and clinically applicable prediction tools; and to discuss the key gaps in the current tools for the risk stratification. In summary, in general clinical settings, the CKM health and associated risk in patients with the metabolic disorder-associated kidney disease can be assessed by combining the CKM staging model, the CKD Prognosis Consortium equations for CKD progression, and the Predicting Risk of CVD Events (PREVENT) equations for CVD. More efficient risk prediction tools, potentially incorporating multimodal data, are needed for more accurate and early identification of individuals at high risk and better personalized management of the disease.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Xu X, Shao X, Hou FF, et al. Risk stratification of metabolic disorder-associated kidney disease. Kidney Int. 2025. PMID: 40157500. doi:10.1016/j.kint.2025.01.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。